How often is rituximab dosed?
Administer RITUXAN as a single-agent every 8 weeks for 12 doses. Following completion of 6-8 cycles of CVP chemotherapy, administer once weekly for 4 doses at 6-month intervals to a maximum of 16 doses. Administer on Day 1 of each cycle of chemotherapy for up to 8 infusions.
How is Rituxan dosed?
A “course” is two 1-gram IV infusions separated by 2 weeks. Rituxan is typically given every 6 months, or based on your doctor’s evaluation of your symptoms. If your symptoms return before it’s time for your next course, you and your healthcare provider may decide to treat earlier (but no sooner than 4 months).
How is rituxan hycela administered?
Drug forms and administration Rituxan Hycela comes as a liquid solution that’s given as a subcutaneous injection (an injection directly under your skin). A healthcare provider will inject the drug in your belly over 5 to 7 minutes. Rituxan also comes as a liquid solution. But it’s given as an intravenous (IV) infusion.
What is MG m2 dosing?
Most drugs in children are dosed according to body weight (mg/kg) or body surface area (BSA) (mg/m2). Care must be taken to properly convert body weight from pounds to kilograms (1 kg= 2.2 lb) before calculating doses based on body weight.
How is rituximab infusion rate calculated?
Standard Infusion: Initiate infusion at a rate of 50 mg/hr. In the absence of infusion toxicity, increase infusion rate by 50 mg/hr increments every 30 minutes, to a maximum of 400 mg/hr. For Pediatric Patients with mature B-cell NHL/B-AL: Initiate infusion at a rate of 0.5 mg/kg/hr (maximum 50 mg/hr).
Is Rituxan and rituximab the same?
Rituxan is the trade name for rituximab. In some cases, health care professionals may use the trade name rituxan when referring to the generic drug name rituximab. Drug type: Rituximab is a monoclonal antibody. (For more detail, see “How this drug works” section below).
How is subcutaneous rituximab administered?
Dosing Information Induction therapy All patients must receive a full dose of rituximab by intravenous infusion (IV), using the IV formulation administered at 375 mg/m2 body surface area, followed by subcutaneous injection of rituximab at a fixed dose of 1400 mg per cycle for up to 8 cycles.
How do you calculate body surface area for medication doses?
The formula is as follows[1]: Body Surface Area= 0.007184 x (Height(m)^0.725) x (Weight(kg)^0.425)
How many times can you give rituximab per infusion?
Rituximab: -Administer as two 1000 mg IV infusions separated by 2 weeks. -Glucocorticoids administered as methylprednisolone 100 mg IV or its equivalent 30 minutes prior to each infusion are recommended to reduce the incidence and severity of infusion reactions.
What are infusion-related reactions (IRR) in rituximab?
The occurrence of infusion-related reactions (IRR), especially during the first infusion, is one of the main concerns of rituximab, otherwise well tolerated. Although IRR are usually mild to moderate, fatal evolutions have been reported.
Does rituximab cause hypersensitivity reactions (HSRs)?
However, increased use of rituximab has been associated with hypersensitivity reactions (HSRs), which can be classified as infusion-related, cytokine-release, type I (IgE/non-IgE), mixed, type III, and type IV reactions. Immediate infusion-related reactions to rituximab are quite common and decrease in frequency with subsequent infusions.
How do you administer rituximab 250 mg/m2 IV?
-Infuse rituximab 250 mg/m2 IV in accordance with the ibritumomab tiuxetan package insert. -Refer to the ibritumomab tiuxetan package insert for full prescribing information. -Initiate infusion at a rate of 20% of the total dose given in the first 30 minutes and administer the remaining 80% of the total dose over the next 60 minutes.